Soligenix (Warrant)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SNGXW and buy or sell other stocks, options, and ETFs commission-free!

About SNGXW

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. 

CEO
Christopher J. Schaber, PhD
CEOChristopher J. Schaber, PhD
Employees
Employees
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1987
Founded1987
Employees
Employees

SNGXW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
52 Week high
52 Week low
52 Week low

SNGXW News

TipRanks 1d
Soligenix extends patent protection for Filovirus Vaccine platform

Soligenix announced that it has received notice of intent to grant additional patents based on its patent application titled “Compositions and Methods of Manufa...

Yahoo Finance 1d
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa - Yahoo Finance

Includes thermostabilized Ebola vaccines MarVax™ and SuVax™ Includes nanoemulsion adjuvant compatible with lyophilization PRINCETON, N.J., April 25, 2024 /PRN...

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.